# Non-investigational Study to Evaluate Adenovirus Serotype 5 (Ad5) Neutralizing Antibodies (nAb) in Patients With Chronic Hepatitis B Virus (HBV) Mono-infection

> **NCT02355951** · NA · COMPLETED · sponsor: **Transgene** · enrollment: 166 (actual)

## Conditions studied

- Chronic Hepatitis B

## Interventions

- **OTHER:** blood draw

## Key facts

- **NCT ID:** NCT02355951
- **Lead sponsor:** Transgene
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-12
- **Primary completion:** 2016-02
- **Final completion:** 2016-02
- **Target enrollment:** 166 (ACTUAL)
- **Last updated:** 2016-02-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02355951

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02355951, "Non-investigational Study to Evaluate Adenovirus Serotype 5 (Ad5) Neutralizing Antibodies (nAb) in Patients With Chronic Hepatitis B Virus (HBV) Mono-infection". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT02355951. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*